Observational Study of Sublingual Microcirculatory Blood Flow Characteristics in Patients Undergoing Transthoracic Esophagectomy

NCT ID: NCT02263664

Last Updated: 2015-06-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

250 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-09-30

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Microcirculatory alterations occur in critically ill patients and those undergoing major surgeries. The severity of perioperative microvascular alterations appear to be related to the severity of organ dysfunction after surgery. Non-cardiac thoracic surgeries comprise a subgroup of high risk surgical procedures which have the potential to significantly affect and impair microcirculatory function but this patient population has not been well studied. Esophagectomy surgery in particular produces a profound systemic inflammatory response which correlates with a number of adverse outcomes. It is likely, though unproven, that microcirculatory derangements may underly these phenomena. Though the study of microcirculatory dysfunction in thoracic surgery is in its infancy, the body of available evidence at this point supports the following hypotheses; that microcirculatory derangements and dysfunction 1) occur during major surgeries including transthoracic esophagectomy 2) may be related to SIRS, 3) may predict adverse outcomes, and 4) may be amenable to modification via specific therapies.

We propose a prospective observational study to determine the effects of transthoracic esophagectomy on microcirculatory function. Two hundred patients meeting inclusion criteria undergoing planned transthoracic esophagectomy via thoracotomy incision will be prospectively enrolled at The University of Virginia. Patients will be followed for 28 days or until discharge from the ICU. Evaluation of the sublingual, gastric serosal and mucosal tissues will be performed using sidestream dark field (SDF) imaging using the CytoCam® by Braedius Medical BV (Huizen, The Netherlands). Scoring of the microcirculation will include an index of vascular density (perfused vessel density), an assessment of capillary perfusion (proportion of perfused vessels and microcirculatory flow index) and a heterogeneity index.

Note: the CytoCam® will only take a series of images as consistent with a microscope of exposed tissue. Also, the FDA Office of Device Evaluations (ODE) General Surgery Devices Branch One - Light Based/laser (GSDB1) has deemed this device to be exempt from 510(K) approval.

http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm?ID=5021

Data from patient's medical charts before and after surgery (30 days post) will be used for elucidation of specific complications. We will use the cardiovascular and respiratory components of the SOFA score as independent measures of organ dysfunction. Acute kidney injury will be defined by the AKIN criteria as an increase of at least 50% above baseline serum creatinine and will be graded from stage 1 to 3.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1\. Provide the scientific background, rationale and relevance of this project. The microcirculation plays a fundamental role in gas and nutrient exchange; it must constantly adapt by controlling vascular tone and regional blood flow. In disease states, increased permeability may be necessary to produce the inflammatory response. The assessment and quantification of the macrovascular hemodynamics and the assumption that it is reflective of microvascular change is fundamentally flawed. Even when global hemodynamic variables are corrected, many patients with circulatory failure will develop multi organ failure and ultimately die. The recent advent of in vivo microcirculation monitoring has begun to improve our understanding of the relationships between surgery, anesthetic management, and regulation of the microcirculation.

Microcirculatory alteration also occurs in patients undergoing cardiac surgery. Bauer et al first reported that microcirculatory perfusion was transiently altered in humans after cardiopulmonary bypass. Similar findings were reported more recently by other groups. , More importantly, these alterations can also be observed in patients who undergo surgery without cardiopulmonary bypass.3 Furthermore the sublingual microcirculation was still slightly abnormal up to 24 h after surgery in these patients. As in non-cardiac surgery, the severity of perioperative microvascular alterations correlated with peak lactate levels and severity of organ dysfunction after surgery.iii High-risk surgery is a new area in which in vivo microcirculatory alterations have been observed. In patients undergoing high-risk non-cardiac surgery, Jhanji et al observed that the density and proportion of perfused capillaries was lower in the 14 patients who subsequently developed postoperative complications than in the 11 patients with an uneventful postoperative course. Subcutaneous tissue PO2 and laser Doppler cutaneous blood flow did not differ between the groups, further highlighting the lack of sensitivity of these methods to detect heterogeneous perfusion. Interestingly, there was no significant difference in global O2 delivery between the groups.

Non-cardiac thoracic surgeries comprise a subgroup of high risk surgical procedures which have the potential to significantly affect and impair microcirculatory function. A study of patients undergoing esophagectomy demonstrated significant impairment of sublingual microcirculation relative to pancreaticoduodenectomy patients. Esophagectomy surgery produces a profound systemic inflammatory response which correlates to a number of adverse outcomes. Interestingly, the time course of microcirculatory impairment and recovery appears to parallel the SIRS typically seen in surgeries of this type. Transthoracic esophagectomy is typically facilitated by one lung ventilation (OLV) in an effort to optimize surgical exposure to the operative hemithorax. The institution of OLV has the potential to dramatically impair tissue oxygen supply demand relationships via adverse effects on systemic oxygen desaturation, as a result of an increased venous admixture from right to left intrapulmonary shunting, as well as decrements in cardiac output. Cerebral oxygen desaturation accompanying OLV is also well described, though the pathophysiology is not well understood. It is likely, though unproven, that microcirculatory derangements may underly these phenomena. Though the study of microcirculatory dysfunction in thoracic surgery is in its infancy, the body of available evidence at this point supports the following hypotheses; that microcirculatory derangements and dysfunction 1) occur during major surgeries including transthoracic esophagectomy 2) may be related to SIRS, OLV or both, 3) may predict adverse outcomes, and 4) may be amenable to modification via specific therapies.

This is a feasibility study to see if the changes in microcirculatory parameters as observed by the SDF device can accurately diagnose anastomotic and other complications for the purpose of leading to a wider study of microcirculatory derangements as an indicator of risk of surgical complications.

Hypothesis to be Tested:

i. Microcirculatory derangements, as indicated by changes in microcirculation of sublingual tissue, serosa tunica near the surgical division, or the mucosal lining of the stomach near the surgical division, occur during transthoracic esophagectomy and in the perioperative period.

ii. Changes in microcirculation predicts post-operative anastomotic complications iii. Changes in microcirculation predicts post-operative complications

Specific Aims

1. Determine whether microcirculatory derangements, as indicated by changes in microcirculation of sublingual tissue, serosa tunica near the surgical division, or the mucosal lining of the stomach near the surgical division, occur during transthoracic esophagectomy involving one lung ventilation (OLV), using a side stream dark field (SDF) imaging system.

1.1. This aim will include measurements of microcirculatory parameters at multiple time points within the perioperative period.
2. Determine the temporal relationship of microcirculatory dysfunction and recovery, if any, at the initiation of OLV, reestablishment of two lung ventilation, and cessation of surgery.

2.1. This aim will include measurements of microcirculatory parameters at multiple time points within the perioperative period.
3. Determine whether observed changes in microcirculation is predictive of postoperative organ dysfunction, and perioperative complications.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transthoracic Esophagectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age 18 through 75 years
2. Subjects are undergoing transthoracic esophagectomy utilizing thoracotomy or thoracoscopy incisions as part of their clinical care. These surgeries include primarily the Ivor Lewis, and three hole (McKeown) esophagectomy procedures and variants thereof.
3. A patent arterial line
4. A patent IV line
5. Must be able to read and speak English
6. Subjects may have current diagnosis of cancer that requires esophagectomy as part of their clinical care.

Exclusion Criteria

1. Subjects unable/unwilling to give informed consent.
2. Cognitively Impaired
3. Prisoners
4. Pregnant females
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Virginia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Randal Blank, MD

Associate Professor, Anesthesiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

RANDAL BLANK, M.D. PH.D

Role: PRINCIPAL_INVESTIGATOR

University of Virginia

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Virginia

Charlottesville, Virginia, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

MARCIA E BIRK

Role: CONTACT

434-982-0230

KEITA IKEDA, PHD

Role: CONTACT

9195931174

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

MARCIA E BIRK

Role: primary

434-982-0230

KEITA IKEDA, PHD

Role: backup

919-593-1174

References

Explore related publications, articles, or registry entries linked to this study.

Bauer A, Kofler S, Thiel M, Eifert S, Christ F. Monitoring of the sublingual microcirculation in cardiac surgery using orthogonal polarization spectral imaging: preliminary results. Anesthesiology. 2007 Dec;107(6):939-45. doi: 10.1097/01.anes.0000291442.69337.c9.

Reference Type BACKGROUND
PMID: 18043062 (View on PubMed)

Atasever B, Boer C, Goedhart P, Biervliet J, Seyffert J, Speekenbrink R, Schwarte L, de Mol B, Ince C. Distinct alterations in sublingual microcirculatory blood flow and hemoglobin oxygenation in on-pump and off-pump coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2011 Oct;25(5):784-90. doi: 10.1053/j.jvca.2010.09.002. Epub 2010 Nov 5.

Reference Type BACKGROUND
PMID: 21115363 (View on PubMed)

Koning NJ, Vonk AB, Meesters MI, Oomens T, Verkaik M, Jansen EK, Baufreton C, Boer C. Microcirculatory perfusion is preserved during off-pump but not on-pump cardiac surgery. J Cardiothorac Vasc Anesth. 2014 Apr;28(2):336-41. doi: 10.1053/j.jvca.2013.05.026. Epub 2013 Oct 23.

Reference Type BACKGROUND
PMID: 24161555 (View on PubMed)

Jhanji S, Lee C, Watson D, Hinds C, Pearse RM. Microvascular flow and tissue oxygenation after major abdominal surgery: association with post-operative complications. Intensive Care Med. 2009 Apr;35(4):671-7. doi: 10.1007/s00134-008-1325-z. Epub 2008 Oct 21.

Reference Type BACKGROUND
PMID: 18936911 (View on PubMed)

van Genderen M, Gommers D, Klijn E, Lima A, Bakker J, van Bommel J. Postoperative sublingual microcirculatory derangement following esophagectomy is prevented with dobutamine. Clin Hemorheol Microcirc. 2011;48(4):275-83. doi: 10.3233/CH-2011-1421.

Reference Type BACKGROUND
PMID: 22012833 (View on PubMed)

Wright CD, Kucharczuk JC, O'Brien SM, Grab JD, Allen MS; Society of Thoracic Surgeons General Thoracic Surgery Database. Predictors of major morbidity and mortality after esophagectomy for esophageal cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database risk adjustment model. J Thorac Cardiovasc Surg. 2009 Mar;137(3):587-95; discussion 596. doi: 10.1016/j.jtcvs.2008.11.042.

Reference Type BACKGROUND
PMID: 19258071 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17551

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.